{
    "nctId": "NCT02936999",
    "briefTitle": "Vitamin D Supplementation in Women With DCIS and/or LCIS",
    "officialTitle": "An Exploratory Pilot Study of Vitamin D Supplementation in Women With DCIS and/or LCIS",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 8,
    "primaryOutcomeMeasure": "Ki 67 Measured",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Subjects must have a tissue diagnosis of lobular carcinoma in situ or ductal carcinoma in situ and being scheduled to undergo excision of their cancer\n* Subjects must be female at least 18 years of age\n* Subjects must have a signed consent\n* Normal liver function based on (total bilirubin and AST \\<1.5 x Upper Limit of Normal)\n* Serum creatinine \\< 2.0 mg/dL\n* Serum 25 (OH) D levels \\< 50 ng/ml\n* Calcium within the normal range (8.5-10.2 mg/dL)\n* ECOG performance status 0-2\n* Are able to swallow and retain oral medication\n* Subjects should be willing to abstain from use of hormonal therapies (e.g. hormone replacement therapy, oral contraceptive pills, hormone-containing IUDs, and E-string)\n\nExclusion Criteria:\n\n* Patient desires not to participate in the study\n* Inability to give consent\n* Current use of hormone-containing forms of birth control such as implants (i.e. Norplants, or injectables (i.e. depo-provera)\n* Currently lactating\n* Patients with history of renal or hepatic insufficiency\n* Used an investigational drug within 30 days or 5 half-lives, whichever is longer, preceding the first dose of study medication\n* History of granulomatous disease such as tuberculosis or sarcoidosis\n* History of Vitamin D supplementation \\> 2000 IU/day within the last 2 months\n* History of hypoparathyroidism",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}